Gapping down
In reaction to disappointing earnings/guidance:
- CVGI -16.8%, TLYS -14.5%, ATRS -10.1%, KURA -9.5%, FENG -9.1%, NCMI -9%, LBRT -7.8%, SFIX -7.3%, DKS -5.3%, MLNT -3.3%, INWK -2.5%, COUP -1.6%, AKBA -1.5%, DSW -1%
M&A news:
- QCOM -5% (Qualcomm acquisition by Broadcom (AVGO) blocked by President Trump)
Other news:
- ADXS -21.7% (announces clinical hold in Axalimogene Filolisbac Phase 1/2 combination study with AstraZeneca's IMFINZI; reprots Q1 results)
- BL -5.5% (prices 8 mln shares of common stock by selling shareholders at $41.50 per share)
- MYGN -4.6% (recently received a Subpoena from the Department of Health and Human Services, Office of Inspector General, in connection with an investigation into possible false or otherwise improper claims submitted for payment under Medicare and Medicaid)
- SNSS -4.4% (announces cancellation of presentation and webcast at Cowen & Company 38th Annual Health Care Conference due to travel changes caused by inclement weather)
- MC -4.3% (prices offering $5 mln shares of common stock at $51.00 per share)
- EDIT -2.8% (files mixed securities shelf offering and files for $150 mln common stock shelf offering)
- SABR -1.7% (prices secondary offering by selling shareholders of of 15 mln shares of common stock at $22.45 per share)
- AWI -1.6% (attributed to block trade pricing)
Analyst comments:
- JCP -2.5% (initiated with Underperform at Credit Suisse)
- FINL -1.9% (light volume; initiated with Underperform at Credit Suisse)